01(s) Sample Clauses

01(s). Notwithstanding the foregoing, (i) no Liens shall be permitted to exist, directly or indirectly, on (a) Pledged Collateral and (b) any Indebtedness of the Borrower or any Subsidiary to the Borrower or a Domestic Subsidiary (unless such Indebtedness shall have become subject to a first priority Lien securing the Obligations), other than Liens in favor of the Administrative Agent for the benefit of the Secured Parties and Liens permitted by Section 6.02(d) or (p) and (ii) no Liens over any deposit account of the Borrower or any Subsidiary Loan Party not in favor of the Administrative Agent for the benefit of the Secured Parties other than Liens permitted by Sections 6.02(b), (d), (f), (g), (k), (o)(i), (o)(ii), (p), (bb) or (ee) shall be perfected. Notwithstanding the foregoing, (i) no Liens will be permitted to exist, directly or indirectly, on any assets or Equity Interests of the Borrower or any Subsidiaries, except to the extent specifically permitted herein and (ii) no Liens will be permitted to exist, directly or indirectly, to the extent such Liens are in regard to Indebtedness for borrowed money, on any assets or Equity Interests of a Subsidiary that is not a Loan Party pursuant to Sections 6.02(l) and (cc) unless such Subsidiary becomes a Loan Party and complies with the Collateral and Guarantee Requirements.
AutoNDA by SimpleDocs
01(s). Liens other than Permitted Liens A. The aggregate amount of Debt and other indebtedness secured by any Liens permitted under Section 7.01(s) of the Agreement: $ ____________ $ ____________ $ ____________ B. The aggregate monetary obligations in respect of transactions permitted pursuant to the proviso of Section 7.03 of the Agreement: $ ____________ $ ____________ $ ____________ C. The applicable amount of all Securitizations of the Borrower and its Restricted Subsidiaries: $ ____________ $ ____________ $ ____________ D. Sum of Lines II.A, II.B, and II.C: $ ____________ $ ____________ $ ____________ E. Total Capital (Line I.B.3): $ ____________ $ ____________ $ ____________ F. 25% of Total Capital (25% of Line II.E): $ ____________ $ ____________ $ ____________ G. Excess (deficiency) (Line II.D – Line II.F): $ ____________ $ ____________ $ ____________
01(s). Section 6.01(s) of the Financing Agreement is hereby amended and restated to read in its entirety as follows:
01(s). If any Term Lender fails to deliver a notice to the Administrative Agent of its election to decline receipt of its Applicable Percentage of any mandatory prepayment within the time frame specified by the Administrative Agent, such failure will be deemed to constitute an acceptance of such Term Lender’s Applicable Percentage of the total amount of such mandatory prepayment of Term Loans.
01(s). Liens other than Permitted Liens
01(s). The following shall be added as Section 5.01(s) to the MLA:
01(s). Section 3.01(s) of the Merger Agreement is hereby amended and restated in its entirety to read as follows:
AutoNDA by SimpleDocs
01(s). Liens other than Permitted Liens A. The aggregate amount of Debt and other indebtedness secured by any Liens permitted under Section 7.01(s) of the Agreement: $ $ $

Related to 01(s)

  • 020A “It is unlawful for any person to transact business in the City without first having obtained a license from the City to do so and without complying with all applicable provisions of this title and paying the fee therefore.”

  • SBC-12STATE 47.1.1 The terms contained in this Agreement and any Appendices, Attachments, Exhibits, Schedules, and Addenda constitute the entire agreement between the Parties with respect to the subject matter hereof, superseding all prior understandings, proposals and other communications, oral or written between the Parties during the negotiations of this Agreement and through the execution and/or Effective Date of this Agreement. This Agreement shall not operate as or constitute a novation of any agreement or contract between the Parties that predates the execution and/or Effective Date of this Agreement.

  • Gentlemen In accordance with the above-referenced Lease, we wish to advise and/or confirm as follows:

  • Attn Board Chair.

  • Ladies and Gentlemen The undersigned refers to the Credit Agreement and hereby gives you irrevocable notice, pursuant to Section [2.2] [2.5] [2.7(a)] of the Credit Agreement, of the borrowing of a [Term Loan][Revolving Loan][Swingline Loan].

  • ORG-0002 Official name: The High Court of Ireland Registration number: The High Court of Ireland Department: The High Court of Ireland Town: Dublin Postcode: X00 XXX0 Country: Ireland Email: XxxxXxxxxXxxxxxxXxxxxx@xxxxxx.xx Roles of this organisation: Review organisation 8.1 ORG-0003

  • Name and Address The name and address of the Members and the amount of each Member’s Capital Commitment are set forth on a confidential schedule maintained as part of the Company’s books and records in the Company’s principal office.

  • Platby (a) Všechny platby budou vypláceny těmto příjemcům (dále jen "Příjemce platby" či "Příjemci platby") v souladu s rozdělením poplatků definovaným v Příloze B: Fakultní nemocni ce v Motol e X Xxxxx 00 000 00 Xxxxx 0, Xxxxx xxxxxxxxx XX 0006420 3 fakturykhl @fnmotol .cz xxx (b) Schválené platby za Klinické hodnocení a související služby, které má Poskytovatel provádět, jsou uvedeny v rozpočtu přiloženém k této Smlouvě jako Příloha B a začleněny zde odkazem ("Příloha B"). Platby uvedené v Příloze B zahrnují všechny příslušné režijní náklady splatné kterékoli Smluvní straně nebo subjektu v důsledku Klinického hodnocení nebo v souvislosti s ním. Poskytovatel bere na vědomí, že společnost Covance nenese odpovědnost za platby, dokud Zadavatel neuhradí takové platby a/nebo splatnou odměnu. Společnost Covance vyvine maximální úsilí, aby získala finanční prostředky od Zadavatele včas s cílem zajistit rychlé zaplacení Příjemci platby. (c) Platby jsou podmíněny postupem v plném souladu s CIP a touto Smlouvou, jakož i včasným a uspokojivým předložením úplných a správných údajů z formulářů subjektů hodnocení (Case Report Form). Příjemce či příjemci plateb nezískají náhradu za subjekty hodnocení, které byly do Klinického hodnocení zařazeny bez řádně provedeného (d) Except as expressly provided for in this Agreement and its exhibits and attachments, no payments will be made to Institution or any other person or entity in connection with the Clinical Investigation. Payment for any costs outside of this Agreement and its exhibits and attachments must be approved in advance in writing by Covance. (e) If a dispute arises between the Parties in respect of any part of an invoice, Covance shall notify Payee promptly of the particulars of the dispute, and Covance may withhold payment of the disputed part of the invoice provided that Covance and Payee endeavor promptly and in good faith to resolve the dispute. (f) Institution shall not bill any third party for any Clinical Investigational Device or other items or services furnished by Sponsor through Covance in connection with the Clinical Investigation, or any services provided to patients in connection with the Clinical Investigation for which payment is made as part of the Clinical Investigation, except as may be specifically authorized by the Exhibit B. 16.

  • 00000 Attn Corporate Secretary and any notice hereunder to you shall be addressed to you at the address indicated in the Company or Subsidiary’s personnel records, subject to the right of either party at any time hereafter to designate in writing some other address.

  • 12A The Secretary of State’s appointed Member (further to Article 12 c) shall become a Member upon the Secretary of State delivering, or posting (by registered post), to the Office of the Academy Trust a notice appointing that person as his Member.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!